UCB Cap Dividend yield

 Price  108.45
 Dividend  1.27
 Earnings  6.57
 Cash-flow  7.86
 Book value  45.19
 Equity  41.32

UCB Cap is part of Pharmaceuticals and Biotechnology business, which is part of Health Care industry. UCB Cap is a company from Belgium and Lux., and his stocks are publicly traded.

UCB Cap paid a total dividend of 240 million EUR last year, for a market value of 20,497 millions (Market Cap 13,083 millions). Dividend per share of UCB Cap is 1.27 EUR, and his stock market price 108.45 EUR.

According to the chart below, where dividend yield is displayed, UCB Cap has a dividend yield of 1.17%, lower than the amount offered by both the market average and companies from Belgium and Lux.. It is also lower than average of Health Care industry. This low dividend yield might has several explanations: company overpriced, expanding their business,...

In addition, you should compare UCB Cap dividend yield with other Pharmaceuticals and Biotechnology companies or firms from Belgium and Lux..

Dividend yield of UCB Cap

UCB Cap Dividend Payout

About the ability of UCB Cap to maintain his current dividend of EUR 1.27 per share, an amount that accounts for 1.17%, we should study its payout ratio both on earnings and on cash-flows (see chart below). UCB Cap payout on ernings is currently 19.33%, which is lower than the market average and companies of Health Care industry, which are 38.25% and 29.07% respectively. Both figures lead us to believe that there is confidence that UCB Capcan maintain his current dividend.

The payout on earnings should be complemented with the payout on cash flow since it is this last amount the one which can be distributed to shareholders. Cash flow per share of UCB Cap is EUR 7.86 per share, which is higher than the dividend per share paid by the company of EUR 1.27, so the company generates enough cash to maintain his dividend in the future.

The following figure shows payout ratios over earnings and cashflow of UCB Cap, compared againt world market average, Belgium and Lux. companies, Health Care industry and Pharmaceuticals and Biotechnology sector companies.

UCB Cap payout

UCB Cap Dividend History

Year Yield  EUR  Paypout  Shares* 

*In millions

UCB Cap Stock performance

Finally, last moth UCB Cap showed a return of 11.00% compared to a worldwide 1.12% average, and a 1.32% of Health Care firms. Over the last year, the company obtained a 33.70% versus a worldwide performance of a 5.73%. More detailed information can be seen in the following graph for Belgium and Lux. and Pharmaceuticals and Biotechnology firms.

UCB Cap stock and market return